Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Articles
DOI: 10.1055/s-0041-1728680
Submitted: 03-07-2022
Published: 03-07-2022

Evaluation of Nutritional Risk and Prevalence of Obesity in Patients with Covid-19 in A Reference Hospital in Salvador, Bahia, Brazil: A Cross-Sectional Study

Nutrology Service, General Surgery Unit, Complexo Hospitalar Universitário Professor Edgard Santos, Salvador, BA, Brazil / Medicine Faculty, Universidade Salvador(UNIFACS), Salvador, BA, Brazil / Life Science Department, Universidade do Estado da Bahia (UNEB), Salvador, BA, Brazil
Medicine Faculty, Universidade Salvador(UNIFACS), Salvador, BA, Brazil
Medicine Faculty, Universidade Salvador(UNIFACS), Salvador, BA, Brazil
Nutrology Service, General Surgery Unit, Complexo Hospitalar Universitário Professor Edgard Santos, Salvador, BA, Brazil
Life Science Department, Universidade do Estado da Bahia (UNEB), Salvador, BA, Brazil
Coronavirus Infections Obesity Nutritional Status Risk Factors Epidemiology

Abstract

Introduction: The Coronavirus has spread to almost every country in the world, causing the coronavirus disease (COVID-19). The coronavirus stands out among the other infections especially by it's high contagious power and important effects on the respiratory system. The COVID-19 has differents ways of presentation and these are influenced by the patient's previous nutricional status, correlated with the patient's lifestyle and comorbities. Objective: this survey seeks to analyze the nutritional status and the prevalence of obesity in patients hospitalized with SARS-CoV-2. Methods: this is a descriptive, prospective and cross-sectional study type, which 41 patients affected by COVID-19 were interviewed. Patient's weight and height were used to assess the BMI, and nutritional risk assessment was performed using the Nutritional Risk Screening tool (NRS 2002). For the analysis, Absolute (AF) and Relative Frequency (RF), the mean and the standard deviation were calculated. Results: It was observerd that 78% of the participants had a high nutritional risk, while only 22% had a low nutritional risk. Besides that, 34% showed overweight and 41.4% showed obesity. Conclusion: the existence of a high prevalence of increased nutritional risk was evidenced, in addition to the high frequency of overweight in patients affected by SARS-CoV-2.

Metrics

Metrics Loading ...

References

  1. Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506 https://linkinghub.elsevier.com/retrieve/pii/S0140673620301835">https://linkinghub.elsevier.com/retrieve/pii/S0140673620301835 cited2020Apr3 [Internet]
  2. Cheng VCC, Lau SKP, Woo PCY, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007; 20 (04) 660-694
  3. Nassar MS, Bakhrebah MA, Meo SA, Alsuabeyl MS, Zaher WA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics. Eur Rev Med Pharmacol Sci 2018; 22 (15) 4956-4961
  4. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020; 109: 102433
  5. Ta S, Bs S, Revisão De Literatura GS, Amadeu De Souza T, Siqueira BS, Grassiolli S. OBESITY, COMORBITIES AND COVID19: A BRIEF LITERATURE REVIEW. Varia Sci - Ciências da Saúde 2020; 6 (01) 72-82 Available from: http://e-revista.unioeste.br/index.php/variasaude/article/view/25403
  6. Hoehl S, Rabenau H, Berger A. et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N Engl J Med 2020; 382 (13) 1278-1280
  7. Jin Y, Yang H, Ji W. et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses 2020; 12 (04) 372 https://www.mdpi.com/1999-4915/12/4/372 cited2020May12 [Internet]
  8. Liu F, Li L, Xu M. et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 2020; 127: 104370
  9. Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract 2020; 164: 108214
  10. Coronavirus Disease (COVID-19) Situation Reports [Internet]. [cited 2020 Nov 12]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
  11. Pal R, Bhadada SK. Managing common endocrine disorders amid COVID-19 pandemic. Diabetes Metab Syndr 2020; 14 (05) 767-771
  12. Ricardo Giacaglia L. COVID-19, OBESIDADE E RESISTÊNCIA À INSULINA. ULAKES J Med Giacaclia, L ULAKES J Med [Internet]. 2020 Jul 20 [cited 2020 Nov 26];1:2020–1. Available from: http://revistas.unilago.edu.br/index.php/ulakes
  13. Busetto L, Bettini S, Fabris R. et al. Obesity and COVID-19: An Italian Snapshot. Obesity (Silver Spring) 2020; 28 (09) 1600-1605
  14. Costa TRM, Correia RS, Silva Pdos S. et al. A obesidade como coeficiente no agravamento de pacientes acometidos por COVID-19. Res Soc Dev 2020; 9 (09) e395997304 cited 2020 Nov 26 DOI: 10.33448/rsd-v9i9.7304.
  15. Piva S, Filippini M, Turla F. et al. Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. J Crit Care 2020; 58: 29-33
  16. Sattar N, McInnes IB, McMurray JJV. Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation 2020; 142 (01) 4-6
  17. Moreira GS, Barros De Souza L, Reis M, Freire PB. Obesidade e agravamento da COVID 19-Artigo de revisão. Heal Resid J - HRJ 2020; 1 (06) 63-70 Available from: https://escsresidencias.emnuvens.com.br/hrj/article/view/27
  18. Kondrup J, Ramussen HH, Hamberg O. et al. Nutritional risk screening (NRS 2002): A new method based on an analysis of controlled clinical trials. Vol. 22, Clinical Nutrition. Churchill Livingstone; 2003: 321-36
  19. Cai Q, Chen F, Wang T. et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care 2020; 43 (07) 1392-1398
  20. Peng Y, Meng K, He M. et al. Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China. J Am Heart Assoc 2020; 9 (19) e016796
  21. Guan WJ, Liang WH, Zhao Y. et al; China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020; 55 (05) 2000547
  22. Galvão MH, Roncalli AG. Português FATORES ASSOCIADOS A MAIOR RISCO DE OCORRÊNCIA DE ÓBITO POR COVID-19: ANÁLISE DE SOBREVIVÊNCIA A PARTIR DE CASOS CONFIRMADOS.
  23. Ministério da Saúde. BOLETIM EPIDEMIOLÓGICO ESPECIAL [Internet]. [cited 2020 Nov 26]. Available from: https://opendatasus.saude.gov.br/
  24. Garcia LP. Dimensões de sexo, gênero e raça na pesquisa sobre COVID-19. Epidemiol e Serv saude Rev do Sist Unico Saude do Bras 2020; 29 (03) e20202207 Available from: https://www.nature.com/articles/d41586-020-01705-x
  25. Nogueira J, Silva DA. OBESIDADE E COVID-19: QUAIS AS EVIDÊNCIAS?. Rev Artig Com 2020; 21: e5346-e5346 Available from: https://www.acervomais.com.br/index.php/artigos/article/view/5346
  26. Estrela FM, Soares CFSE, Cruz MAD. et al. Covid-19 Pandemic: reflecting vulnerabilities in the light of gender, race and class. Cien Saude Colet 2020; 25 (09) 3431-3436

How to Cite

Pimentel, R. F. W., Moraes, G. C. de, Barcelos, S. G. C., Figueiredo, P. C. M. de, & Merces, M. C. D. (2022). Evaluation of Nutritional Risk and Prevalence of Obesity in Patients with Covid-19 in A Reference Hospital in Salvador, Bahia, Brazil: A Cross-Sectional Study. International Journal of Nutrology, 14(1), 11–15. https://doi.org/10.1055/s-0041-1728680